
    
      Randomized, Single-Masked Phase II study for subjects previously enrolled in Phase I and II
      studies for wet age-related macular degeneration with VEGF Trap-Eye intravitreal injection as
      treatment.Long term (3 years) treatment is intended to measure safety and tolerability, as
      well as frequency of re-treatment and the effect of VEGF Trap-Eye on best corrected visual
      acuity (BCVA).
    
  